tolvaptan has been researched along with Water-Electrolyte Imbalance in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, A; Haze, T; Hirawa, N; Katsumata, M; Kawano, R; Kobayashi, Y; Komiya, S; Ohki, Y; Ozawa, M; Saka, S; Suzuki, S; Tamura, K | 1 |
| Broch, MJ; Castellanos-Ortega, Á; Gordon, M; Pinos, A; Ramírez, P; Ruiz-Ramos, J; Sosa, M; Villarreal, E | 1 |
| Akimoto, T; Imai, T; Maeshima, A; Masuda, T; Miki, A; Miyazawa, Y; Murakami, T; Muto, S; Myoga, A; Nagata, D; Nakagawa, S; Ohara, K; Okada, M; Saito, O; Sekiguchi, C; Sugase, T; Yoshizawa, H | 1 |
| Hirai, H; Hosono, M; Kaku, D; Kubota, Y; Nakahira, A; Sasaki, Y; Shibata, T; Suehiro, S; Suehiro, Y | 1 |
| Hata, H; Iida, M; Osaka, S; Sezai, A; Shiono, M; Yoshitake, I | 1 |
| Albicini, M; Gandola, A; Iapichino, G; Mantovani, E; Ottolina, D; Pezzi, A; Pirrone, M; Spanu, P | 1 |
| Ayuk, J; Bouloux, PM; Cohen, M; Cranston, I; Grant, P; Grossman, A; Murray, RD; Rees, A; Thatcher, N | 1 |
| Arai, T; Atsukawa, M; Itokawa, N; Iwakiri, K; Kondo, C; Nakagawa, A; Narahara, Y; Okubo, T; Tsubota, A | 1 |
| Fujinaga, K; Ito, H; Mizumoto, T; Sawada, Y; Shimpo, H; Tempaku, H | 1 |
| Amano, T; Ando, H; Mizuno, T; Mukai, K; Nakano, Y; Niwa, T; Takashima, H; Wakabayashi, H; Waseda, K; Watanabe, A | 1 |
| Chandler, A; Dhingra, R; Dowling, D; Eisen, H; Fileccia, R; Gordon, P; Gregory, D; Gupta, D; Haught, WH; Kiernan, M; Konstam, JM; Konstam, MA; Korr, K; Massaro, JM; Mody, FV; Patten, R; Pressler, SJ; Romeling, M; Udelson, JE; Wagoner, L; Wedge, P | 1 |
| Farmakis, D; Filippatos, G; Gheorghiade, M; Kremastinos, DT | 1 |
| Kettritz, R; Luft, FC | 1 |
| Cirulli, J; Friedman, B | 1 |
| Kamyar, M; Lemmens-Gruber, R | 1 |
| Batlle, D; Chen, S; Jalandhara, N | 1 |
5 review(s) available for tolvaptan and Water-Electrolyte Imbalance
| Article | Year |
|---|---|
Vasopressin and vasopressin antagonists in heart failure and hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Humans; Hyponatremia; Infusions, Intravenous; Male; Prognosis; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Risk Assessment; Survival Rate; Tolvaptan; Water-Electrolyte Imbalance | 2008 |
[Disorders of fluid and electrolyte balance].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Deamino Arginine Vasopressin; Humans; Hyperkalemia; Hypernatremia; Hyponatremia; Inappropriate ADH Syndrome; Membrane Potentials; Morpholines; Osmolar Concentration; Potassium; Randomized Controlled Trials as Topic; Sodium; Spiro Compounds; Survival Rate; Tolvaptan; Water-Electrolyte Imbalance | 2011 |
Hyponatremia in critical care patients: frequency, outcome, characteristics, and treatment with the vasopressin V2-receptor antagonist tolvaptan.
Topics: Age Factors; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Temperature; Creatinine; Critical Care; Health Status Indicators; Humans; Hyponatremia; Intensive Care Units; Prevalence; Tolvaptan; Water-Electrolyte Imbalance | 2013 |
Vasopressin antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Binding Sites; Cardiovascular Diseases; Clinical Trials as Topic; Hormone Antagonists; Humans; Indoles; Pyrroles; Pyrrolidines; Tolvaptan; Vasopressins; Water-Electrolyte Imbalance | 2006 |
Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyponatremia; Male; Prognosis; Receptors, Vasopressin; Risk Assessment; Severity of Illness Index; Tolvaptan; Treatment Outcome; Water-Electrolyte Imbalance | 2007 |
3 trial(s) available for tolvaptan and Water-Electrolyte Imbalance
| Article | Year |
|---|---|
Efficacy of tolvaptan on advanced chronic kidney disease with heart failure: a randomized controlled trial.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Furosemide; Heart Failure; Humans; Renal Insufficiency, Chronic; Sodium; Tolvaptan; Water-Electrolyte Imbalance | 2022 |
Efficacy and Safety Evaluation of Tolvaptan on Management of Fluid Balance after Cardiovascular Surgery Using Cardiopulmonary Bypass.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Cardiopulmonary Bypass; Cardiovascular Surgical Procedures; Diuretics; Drug Monitoring; Drug Therapy, Combination; Female; Furosemide; Humans; Kidney Function Tests; Male; Middle Aged; Postoperative Complications; Spironolactone; Tolvaptan; Treatment Outcome; Water-Electrolyte Balance; Water-Electrolyte Imbalance | 2016 |
Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Dyspnea; Female; Heart Failure; Humans; Male; Middle Aged; Tolvaptan; Water-Electrolyte Imbalance | 2017 |
9 other study(ies) available for tolvaptan and Water-Electrolyte Imbalance
| Article | Year |
|---|---|
Vasopressin antagonist efficacy and safety in volume-overloaded critically ill patients: a new therapeutic alternative.
Topics: Antidiuretic Hormone Receptor Antagonists; Critical Illness; Diuresis; Diuretics; Female; Humans; Male; Middle Aged; Prospective Studies; Tolvaptan; Treatment Outcome; Water-Electrolyte Imbalance | 2020 |
Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzhydryl Compounds; Body Composition; Female; Fluid Shifts; Furosemide; Glucosides; Humans; Male; Prospective Studies; Renal Insufficiency, Chronic; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Tolvaptan; Treatment Outcome; Water-Electrolyte Balance; Water-Electrolyte Imbalance | 2019 |
Case report: new treatment with Tolvaptan for heart failure after cardiac surgery.
Topics: Benzazepines; Diuretics; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Tolvaptan; Treatment Outcome; Water-Electrolyte Imbalance | 2014 |
Hypo-osmolar fluid absorption in endoscopic resection: a new pharmacological approach.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Endoscopy; Female; Humans; Hypotonic Solutions; Osmolar Concentration; Postoperative Complications; Tolvaptan; Water; Water-Electrolyte Imbalance | 2015 |
The diagnosis and management of inpatient hyponatraemia and SIADH.
Topics: Algorithms; Anti-Bacterial Agents; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Demeclocycline; Fluid Therapy; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Practice Guidelines as Topic; Tolvaptan; Water-Electrolyte Imbalance | 2015 |
Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Edema; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Patient Selection; Portal Pressure; Predictive Value of Tests; Prospective Studies; Time Factors; Tolvaptan; Treatment Outcome; Water-Electrolyte Balance; Water-Electrolyte Imbalance | 2016 |
Efficacy of Tolvaptan on Fluid Management After Cardiovascular Surgery Using Cardiopulmonary Bypass.
Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Diuresis; Drug Administration Schedule; Female; Humans; Male; Oxygen Inhalation Therapy; Postoperative Care; Retrospective Studies; Tolvaptan; Urine; Water-Electrolyte Imbalance; Weight Loss | 2016 |
Predictability of tricuspid annular plane systolic excursion for the effectiveness of tolvaptan in patients with heart failure.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; ROC Curve; Systole; Tolvaptan; Tricuspid Valve; Tricuspid Valve Insufficiency; Water-Electrolyte Imbalance | 2017 |
New drug fights fluid build-up. Medication may relieve a common heart failure symptom.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Heart Failure; Humans; Tolvaptan; Water-Electrolyte Balance; Water-Electrolyte Imbalance | 2004 |